Icon has reached a preliminary agreement with Intel to use the Intel Pharma Analytics Platform in clinical trials. Launched in 2013, the Intel platform can continuously monitor and collect clinical ...
Gelsinger's comments offended TSMC, which did not honor discount Revenue and stock price have declined sharply under Gelsinger Intel's 18A chip process faces delays and technical issues Oct 29 ...
The Silicon Valley chipmaker’s journey from icon to a government project, with the sale of a 10 percent stake to the Trump administration, underlines how even the mightiest in tech can fall. By Tripp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback